from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2356c/PPE40

LFCtreatmentdescriptionclass of inhibitor

0.166

Amikacinug/mL Amikacintranslation

0.349

Cap5-10ug/mL Capreomycintranslation

0.131

Rox10-50 ug/mL Roxithromycintranslation

-0.969

SM2-5 ug/mL Streptomycintranslation

-1.067

Tet5-10 ug/mL Tetracyclinetranslation

1.153

Rif0.2-5ug/mL Rifampicintranscription

0.018

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.011

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.707

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.585

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.237

Clofazimine10-13 ug/mL Clofaziminerespiration

0.447

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.013

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.468

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.872

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.875

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.615

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.822

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.230

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.849

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.429

KCN5-20 ug/mL Potassium cyaniderespiration

-0.150

NaN30.2-2 mM Sodium aziderespiration

1.057

Nigericin50 uM Nigericinrespiration

0.378

TRC10-150 ug/mL Triclosanrespiration

-1.332

TRZ10-25 ug/mL Thioridazinerespiration

0.729

Valinomycin0.5-10 uM Valinomycinrespiration

-1.208

ZnSO42 mM ZnSO4respiration

-1.959

menadione6-10 ug/mL Menadionerespiration

-0.263

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.382

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.287

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.648

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.713

NRP_1Non-replicating persistence stage 1dosRassociated

-0.279

Amp0.2mg/mL AmpicillincellWall

-0.291

Cephalexin20-100 ug/mL CephalexincellWall

0.670

Cerulenin0.32-5 ug/mL CerulenincellWall

0.779

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.246

EMB10-20 ug/mL EthambutolcellWall

0.034

Eta12-40 ug/mL EthionamidecellWall

-0.345

INH0.2-0.4 ug/mL IsoniazidcellWall

0.096

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.809

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.405

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.471

BZA0.12 mg/mL BenzamidearomaticAmides

0.861

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.462

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.044

H2O24 mM hydrogen peroxideDNAdamaging

-0.424

Levo10 ug/mL LevofloxacinDNAdamaging

0.551

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.782

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.540

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.316

UVUV-irradiationDNAdamaging

-1.337

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.636

Antimycin12.5-50 ug/mL Antimycin A?

-0.527

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.016

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.167

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.126

PA8240.2-2 ug/mL PA-824?

0.421

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.129

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.365

Verapamil50 uM Verapamil?

-1.129

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.639

methoxatin10-20 ug/mL Methoxatin?